ILM1 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Medios AG is a holding company, which engages in the provision of pharmaceutical drugs. It operates through the following segments: Pharmaceutical Supply, Patient-Specific Therapies, and Services. The Pharmaceutical Supply segment focuses on specialty pharmaceuticals for chronic and/or rare diseases. The Patient-Specific Therapies segment involves in the manufacturing of medications. The Services segment consists of the Groups other activities. The company was founded in 1980 and is headquartered in Berlin, Germany.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
ILM1 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company